Abraxane and Fall - a phase IV clinical study of FDA data
Summary:
Fall is reported as a side effect among people who take Abraxane (paclitaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have Pancreatic carcinoma.
The phase IV clinical study analyzes which people have Fall when taking Abraxane. It is created by eHealthMe based on reports of 19,123 people who have side effects when taking Abraxane from the FDA, and is updated regularly.
What is Abraxane?
Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.
What is Fall?
Fall is found to be associated with 3,281 drugs and 3,755 conditions by eHealthMe. Check the latest studies of Fall.
19,123 people reported to have side effects when taking Abraxane.
Among them, 193 people (1.01%) have Fall.

Among these 193 people:
How long have people been on Abraxane when they have Fall? *
What is the gender of people who have Fall when taking Abraxane? *
What is the age of people who have Fall when taking Abraxane? *
What are other drugs people take besides Abraxane? *
What are other side effects people have besides Fall? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Abraxane and have Fall?
- Check whether Fall is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abraxane:
- Abraxane (19,196 reports)
Fall treatments and more:
- Fall (403,513 reports)
How severe was Fall and when was it recovered:
Expand to all the drugs that have ingredients of paclitaxel:
- Fall and drugs with ingredients of paclitaxel (1,338 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Abraxane side effects:
- Abraxane side effect: Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) (1,185 reports)
- Abraxane side effect: Anaemia (lack of blood) (1,134 reports)
Browse all side effects of Abraxane:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Fall:
- Aspirin side effect: Fall (25,596 reports)
- Prednisone side effect: Fall (19,377 reports)
- Humira side effect: Fall (16,822 reports)
- Gabapentin side effect: Fall (15,328 reports)
- Methotrexate side effect: Fall (14,963 reports)
- Omeprazole side effect: Fall (14,388 reports)
- Vitamin d side effect: Fall (14,261 reports)
- Furosemide side effect: Fall (14,091 reports)
- Metformin side effect: Fall (13,656 reports)
- Fosamax side effect: Fall (13,626 reports)
Browse all the drugs that are associated with Fall:
- Fall (3,281 drugs)
Common conditions associated with Fall:
- Ms hug: 45,332 reports
- Arthritis - rheumatoid: 31,178 reports
- Osteoporosis: 23,545 reports
- Thin bones: 22,826 reports
- Hypertension aggravated: 22,366 reports
- Hbp: 22,278 reports
- Pain exacerbated: 16,156 reports
- Hypnosis and pain: 15,965 reports
- Parkinson's disease: 13,033 reports
- Parkinsonism: 13,022 reports
Browse all the conditions that are associated with Fall:
- Fall (3,755 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Abraxane) and Abraxane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Constipation and drugs of ingredients of phosphate salts - a second ago
- Drug interactions of Eligard and Nitrol - 3 seconds ago
- Could Lupron cause Foetal Exposure During Pregnancy? - 4 seconds ago
- Could Carbachol cause Dyspnea Exacerbated? - 5 seconds ago
- Could Vicodin Es cause Abdominal Pain? - 6 seconds ago
- Could Benazepril Hydrochloride And Hydrochlorothiazide cause Dizziness? - 26 seconds ago
- Pulmonary Arterial Pressure Increased and drugs of ingredients of trazodone hydrochloride - 34 seconds ago
- Drug interactions of Reglan and Enulose - 38 seconds ago
- Drug interactions of Nelarabine and Clofarabine - 39 seconds ago
- Levothyroxine Sodium and Appetite Decreased for Women aged 20-29 - 42 seconds ago